Click on one of these terms to refine your search
1 to 10 of 73 literature results
Progression-free survival (PFS) is increasingly used as an endpoint for cancer clinical trials. Disease progression is typically assessed on the basis…
Authors: Katherine S Panageas, Leah Ben-Porat, Maura N Dickler, Paul B Chapman, Deborah Schrag
Source: Journal of the National Cancer Institute. 2007 Mar 21
View Full TextOBJECTIVE: To evaluate the patterns of care in elderly glioblastoma (GBM) patients from a large population-based registry. METHODS: We identified a co…
Authors: Fabio M Iwamoto, Anne S Reiner, Katherine S Panageas, Elena B Elkin, Lauren E Abrey
Source: Annals of neurology. 2008 Dec
View Full TextBACKGROUND: Strong associations between provider (i.e., hospital or surgeon) procedure volumes and patient outcomes have been demonstrated for many ty…
Authors: Deborah Schrag, Craig Earle, Feng Xu, Katherine S Panageas, K Robin Yabroff, Robert E Bristow, Edward L Trimble, Joan L Warren
Source: Journal of the National Cancer Institute. 2006 Feb 1
View Full TextBACKGROUND: Completion lymph node dissection (CLND), although considered a standard approach for patients with melanoma and a positive sentinel lymph …
Authors: T Peter Kingham, Katherine S Panageas, Charlotte E Ariyan, Klaus J Busam, Mary Sue Brady, Daniel G Coit
Source: Annals of surgical oncology. 2010 Feb
View Full TextBACKGROUND: A large body of literature documents associations between the volume of cases a hospital or surgeon treats and clinical outcomes. Most of …
Authors: Katherine S Panageas, Deborah Schrag, Elyn Riedel, Peter B Bach, Colin B Begg
Source: Annals of internal medicine. 2003 Oct 21
View Full TextBACKGROUND: The current study was conducted to evaluate the patterns of care and survival of older adults with oligodendroglioma (OLI) and astrocytoma…
Authors: Fabio M Iwamoto, Anne S Reiner, Lakshmi Nayak, Katherine S Panageas, Elena B Elkin, Lauren E Abrey
Source: Cancer. 2009 Dec 1
View Full TextBACKGROUND: The pathologic status of the sentinel lymph node (SLN) is a powerful prognostic factor for patients with intermediate thickness melanoma. …
Authors: Carl R Schmidt, Katherine S Panageas, Daniel G Coit, Ami Patel, Mary S Brady
Source: Annals of surgical oncology. 2009 Apr
View Full TextBACKGROUND: In systemic non-Hodgkin lymphoma (NHL), tumors that resemble germinal center B-cells are less aggressive than tumors that resemble postger…
Authors: Oren Levy, Lisa M Deangelis, Daniel A Filippa, Katherine S Panageas, Lauren E Abrey
Source: Cancer. 2008 Jan 1
View Full TextBACKGROUND: The most effective treatment for a new diagnosis of primary central nervous system lymphoma is high-dose methotrexate (MTX)-based chemothe…
Authors: Meltem Ekenel, Fabio M Iwamoto, Leah S Ben-Porat, Katherine S Panageas, Joachim Yahalom, Lisa M DeAngelis, Lauren E Abrey
Source: Cancer. 2008 Sep 1
View Full TextBACKGROUND: An understanding of the methods of detection of recurrent melanoma after sentinel lymph node biopsy (SLNB) is essential for the coordinati…
Authors: Kimberly Moore Dalal, Qin Zhou, Katherine S Panageas, Mary S Brady, David P Jaques, Daniel G Coit
Source: Annals of surgical oncology. 2008 Aug
View Full Text